Portfolio Update

RNS Number : 7396R
Intl. Biotechnology Trust PLC
18 June 2018
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

 

 

Portfolio Update as at 31 May 2018

 

Net Assets

£235m

Net Assets per share

626p

Share price

595p

Total value of unquoted investments

£23m

Total number of portfolio companies

78

Dividend

4% of NAV per annum

 

Top Ten Quoted Investments

 

Company Name

% NAV

Neurocrine

5.5

Celgene

4.8

Biogen

4.3

Vertex

4.1

Array

4.0

Illumina

3.9

Sage

3.9

Morphosys

3.7

Genmab

3.6

Adamas

3.4


-----------

Total

41.2

 

Geographical Allocation

% NAV

US & Canada

86

Europe

14


-----------

Total

100

 

 

Quoted/Unquoted Allocation

% NAV

Quoted

90

Unquoted

10


-----------

Total

100

 

 

NAV % Market Cap

% NAV

Large Cap >USD10BN

35

Mid Cap =USD1-10BN

41

Small Cap <USD1BN

24


-----------

Total

100

 

 

NAV % by Therapeutic Areas

% NAV

Oncology

43

CNS

16

Rare diseases

11

Inflammation

6

Ophthalmology

6

Infectious Diseases

3

Metabolic

3

Medtech

2

Other

10


-----------

Total

100

 

                                        

 

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

18 JUNE 2018


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUBDGDLBDBBGII
UK 100

Latest directors dealings